618
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population

, , , , &
Pages 784-792 | Accepted 28 Mar 2013, Published online: 26 Apr 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chris M. Kozma, Mike Ingham, Andy Paris & Lorie Ellis. (2015) Effectiveness of step therapy policies for specialty pharmaceuticals in immune disorders. Journal of Medical Economics 18:8, pages 646-653.
Read now

Articles from other publishers (9)

Ahmed Al-jedai, Hadeel Alkofide, Lujaine Almohimeed, Lama Alsalim, Alya Alruwaili, Dema A. Alissa & Hajer Almudaiheem. (2023) The impact of a restricted pregabalin prescription policy on drug utilization: An observational multicenter study. Saudi Pharmaceutical Journal 31:12, pages 101851.
Crossref
Kelly L. LenahanDonald E. NicholsRebecca M. GertlerJames D. Chambers. (2021) Variation In Use And Content Of Prescription Drug Step Therapy Protocols, Within And Across Health Plans. Health Affairs 40:11, pages 1749-1757.
Crossref
Taruja KarmarkarRobert W DuboisJennifer S Graff. (2021) Stakeholders find that step therapy should be evidence-based, flexible, and transparent: assessing appropriateness using a consensus approach. Journal of Managed Care & Specialty Pharmacy 27:2, pages 268-275.
Crossref
Brett R. Stacey, Jonathan Liss, Regina Behar, Alesia Sadosky, Bruce Parsons, Elizabeth T. Masters & Patrick Hlavacek. (2017) A systematic review of the effectiveness of policies restricting access to pregabalin. BMC Health Services Research 17:1.
Crossref
Yujin ParkSyed RazaAneesh GeorgeRumjhum AgrawalJohn Ko. (2017) The Effect of Formulary Restrictions on Patient and Payer Outcomes: A Systematic Literature Review. Journal of Managed Care & Specialty Pharmacy 23:8, pages 893-901.
Crossref
Rolin L. Wade, Chi-Chang Chen, Ajita P. De & Jaren C. Howard. (2017) Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans. Journal of Health Economics and Outcomes Research 5:1, pages 75-88.
Crossref
Ibrahim M. AbbassEleanor O. CaplanDaniel B. NgRita KristyCarol R. SchermerPamela BradtJenna M. CollinsWai Man Maria ChanBrandon T. Suehs. (2017) Impact of Overactive Bladder Step Therapy Policies on Medication Utilization and Expenditures Among Treated Medicare Members. Journal of Managed Care & Specialty Pharmacy 23:1, pages 27-37.
Crossref
Carolyn MartinKevin OdellJoseph C. CappelleriTim BancroftRachel HalpernAlesia Sadosky. (2016) Impact of a Novel Cost-Saving Pharmacy Program on Pregabalin Use and Health Care Costs. Journal of Managed Care & Specialty Pharmacy 22:2, pages 132-144.
Crossref
Hilary E. D. Placzek, Elizabeth T. Masters, Tao Gu, Joseph C. Cappelleri, Thomas E. Wasser, Andrew G. Clair, Joseph P. Cook & Debra F. Eisenberg. (2015) Prior Authorization in the Treatment of Patients with pDPN and FM. Pain Practice 15:1, pages E9-E19.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.